Gilteritinib in the management of acute myeloid leukemia: Current evidence and future directions. Nuhoglu Kantarci E, Eskazan AE. Leuk Res 2022;114:106808.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nuhoglu Kantarci E, Eskazan AE. Gilteritinib in the management of acute myeloid leukemia: Current evidence and future directions. Leuk Res 2022;114:106808.
PMID: 35176548